Sitemap
Update: July 26th, 2009
Sitemap of posts on Orshe.com
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64
Posts
- Category: Wall Street Journal (continued)
- Amgen, GSK to Launch Joint Sales Attack for Bone Drug
- Amid Reform Talk, Alternative Medicine Gets Some Love
- Ample Supplies of Shingles Vaccine Return
- An ER Doc Grapples With ‘Unnecessary’ Hospital Admissions
- An Ill Wind Blows Through Pharmaceuticals
- An M.D. On How Money Drives Medical Testing
- An Old Dairy Farm Turned Australian Estate
- An Ounce of Prevention May Not Equal a Penny Saved — And That’s OK
- Analysts Like J&J’s Deal for Cougar
- Analysts Question Aetna on CVS Caremark Deal
- Analysts React to FDA Panel: ‘It Wasn’t a Perfect Day for Amgen’
- Anatomy of a Market: Shedding Light on Cadaver Commerce
- Ancient Rainforest Toothache Remedy Nears Market
- And Here’s the Bill to Block Medicare Pay Cuts to Doctors
- And Orexigen’s Contrave Makes 3: FDA Rejects (Another) Diet Drug
- And Sanofi Makes Three: More Data That One Shot Will Do Against Swine Flu
- And They’re Off! Two J&J Execs in CEO Succession Race
- Ann Arbor School for Students With Aspergers
- Annual X-Rays Fail to Cut Lung-Cancer Deaths
- Another Appeals Court Finds Health Law Constitutional
- Another Cholesterol Drug to Join the U.S. Market
- Another Diabetes Drug is Linked to Pancreas Inflammation
- Another Emory Psychiatrist Draws Fire for Payments From Glaxo
- Another FDA Advisory Panel Meeting: This Time, It’s Avastin
- Another Health-Care Bill Detail: Cap On Flex Spending Accounts
- Another Japanese Drugmaker Makes Another Foreign Acquisition
- Another Medicare Payment Deadline Blown: Prepare for AMA Ads
- Another Outbreak of E. Coli in Germany
- Another Potential Plavix Competitor: AstraZeneca’s Brilinta
- Another Recall at J&J — With More Likely to Come
- Another Twist in the Chronicles of Avandia!
- Answers to Some of Your Burning Sunscreen Questions
- Antibiotic-Resistant Salmonella May Be Tied to Ground Turkey
- Antibiotics Do No Good for Most Sinus Infections – New Guidelines
- Antidepressant Alternative for Pregnant Women: Shock Therapy
- Antidepressants May Help Reduce Levels of Alzheimer’s Marker
- Antipsychotic Drugs, Elderly Patients and Omnicare’s Settlement
- Antipsychotics, Diabetes & Kids
- Antipsychotics, Nursing Homes and the Feds’ Case Against J&J
- Appeals Court Rejects Health-Law Challenges
- Appeals Court Rules Against Health-Care Overhaul Law
- Appeals Court Says Embryonic Stem-Cell Research Can Proceed
- Apple’s Steve Jobs on Course to End Medical Leave
- Applying for Residencies, Med School Grads Are Put On the Spot
- Applying Venture Philanthropy to Chronic Fatigue Syndrome
- Approval Expected for New Inhaled Form of Insulin
- Approval of Effient, a Plavix Rival, Boosts Japanese Drug Maker
- Après Provenge Le Déluge: Focus Turns to Pricing, Availability
- Are Children Selfish?
- Are Clues to Kawasaki Disease Blowing In the Wind?
- Are Doctors Always Honest With Patients?
- Are Egg-Donor Ads Offering to Pay Too Much?
- Are Functional Chocolates Good For You?
- Are Mammograms and PSA Tests Overrated?
- Are NYC Anti-Binge Drinking Ads on the Right Track?
- Are Pharma Reps Salespeople or ‘Robots’?
- Are Public-Private Partnerships the Way to Cut Dietary Sodium?
- Are Some Diet Drugs Rising From the Ashes?
- Are Some Teenagers Wired for Addiction?
- Are States Jumping into the (High-Risk Insurance) Pool?
- Are You a Surgeon? Sorry, You’re Going to Be Sued By Age 65.
- Are You More Intelligent By Yourself?
- Are ‘Patients’ the Same as ‘Consumers’?
- Arena Shares Fall After FDA Document Raises Lorcaserin Safety Issues
- Armadillo Linked to Leprosy Cases
- Armadillos Linked to Leprosy Cases
- Army Says Faked Medical Study Involves ‘Ghost’ Soldiers
- As ASCO Kicks Off, Amgen Hopes Prolia Will Become Cancer Drug
- As Don Berwick Leaves for CMS, A New Leader for IHI
- As FDA Meeting on Avandia Looms, IOM Delivers Report
- As Food-Safety Push Grows, Consumers Sort Out Dos, Don’ts
- As Health Costs Bite Aetna, Analysts Downgrade Stock
- As Health-Care Finale Gets Closer, Both Sides Boost Spending
- As Hospital Amenities Gain Importance, Is it Time for Scrutiny?
- As Medicare Feels Pinch, Sebelius Puts Health-Reform Odds at 75-25
2009 -